The article reports on the approval of new magnetic resonance imaging (MRI) uses for the VNS Therapy System of Cyberonics by the U.S. Food and Drug Administration (FDA). The system will be used for the treatment of refractory epilepsy and treatment-resistant depression. The significance of ...